Phyllanthus emblica L. (Indian gooseberry) extracts protect against retinal degeneration in a mouse model of amyloid beta-induced Alzheimer's disease
- Authors
- Jang, Holim; Srichayet, Phisamai; Park, Woo Jung; Heo, Ho Jin; Kim, Dae-Ok; Tongchitpakdee, Sasitorn; Kim, Tae-Jin; Jung, Sang Hoon; Lee, Chang Yong
- Issue Date
- Oct-2017
- Publisher
- Elsevier BV
- Keywords
- Indian gooseberry; Retinal degeneration; Alzheimer's disease; Amyloid beta
- Citation
- Journal of Functional Foods, v.37, pp 330 - 338
- Pages
- 9
- Indexed
- SCIE
SCOPUS
- Journal Title
- Journal of Functional Foods
- Volume
- 37
- Start Page
- 330
- End Page
- 338
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/13423
- DOI
- 10.1016/j.jff.2017.07.056
- ISSN
- 1756-4646
2214-9414
- Abstract
- This study was to evaluate the protective effect of Phyllanthus emblica L. (Indian gooseberry) on retinal degeneration in a well-characterized animal model of Alzheimer's disease. RGC-5 cells were treated with Indian gooseberry extract (IGE), and intracellular antioxidant activity was evaluated. IGE was orally administered to mice for 21 days, then amyloid beta (All) was administered by intracerebroventricular injection to induce neuronal damage in the brain and retina, and enucleated eyes were collected from the mice and analyzed using western blots and histological assays. As a result, we found that IGE inhibited intracellular oxidative stress and reduced the severity of histological changes caused by A(3-induced retinal degeneration in retinal tissue. Furthermore, it regulated the levels of neurofilament (NF)-L, thymocyte differentiation antigen 1 (Thy-1), and sirtuin 1 (SIRT1) in the retina. These findings demonstrate that IGE protects against retinal degeneration and suggest that this effect is attributable to its antioxidant properties. (C) 2017 Elsevier Ltd. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.